Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 137
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vet J ; 295: 105986, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-37141933

RESUMEN

Absence seizures are a type of generalized onset seizure associated in humans with brief activity interruptions, unresponsiveness and staring. Absence seizures are infrequently reported in veterinary patients, visually indistinguishable from focal seizures, and so may be grouped as non-generalized tonic clonic seizures (non-GTCS). The objective of this retrospective study was to provide a preliminary understanding of the frequency of non-GTCS in dogs and estimate its prevalence by evaluating the distribution of seizure types presented to a referral hospital over 4 years (May 2017-April 2021), as determined from the medical record history and electroencephalography (EEG) diagnostic testing where available. A total of 528 cases were included via a medical record search for dogs with epilepsy and/or seizures presented to the neurology or emergency services. Cases were categorized into seizure types based on reported clinical signs. Each year, 53-63 % of seizure cases were described as generalized tonic clonic seizures (GTCS), 9-15 % GTCS with additional events and 29-35 % suspected non-GTCS. EEG confirmed absence seizures in 12 of 44 EEGs, 5 cases having a history of GTCS and seven without prior GTCS. This preliminary study suggests that non-GTCS may be relatively common as one third of seizure cases in the referral population presented with non-GTCS clinical signs. Prospective studies using EEG are merited to definitively determine the prevalence of these different seizure types in dogs. Acknowledging the impact of these seizures will improve awareness, aiding veterinarians in their recognition, diagnosis and potential treatment options.


Asunto(s)
Enfermedades de los Perros , Epilepsia Tónico-Clónica , Epilepsia , Humanos , Perros , Animales , Epilepsia Tónico-Clónica/diagnóstico , Epilepsia Tónico-Clónica/tratamiento farmacológico , Epilepsia Tónico-Clónica/veterinaria , Estudios Retrospectivos , Estudios Prospectivos , Convulsiones/diagnóstico , Convulsiones/epidemiología , Convulsiones/veterinaria , Epilepsia/diagnóstico , Epilepsia/epidemiología , Epilepsia/veterinaria , Electroencefalografía/veterinaria , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/epidemiología
2.
Radiat Prot Dosimetry ; 183(1-2): 32-35, 2019 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-30753692

RESUMEN

To identify the precise molecular processes to induce DNA lesions, we attempt a novel spectroscopy of X-ray induced luminescence (XIL) using soft X-ray synchrotron radiation, which is a non-destructive analysis of the reaction intermediates in the elementary reaction pathway of damage induction and self-organized restoration. Using a liquid micro-jet technique to introduce aqueous samples in a vacuum chamber, we measure UV-visible luminescence from nucleotide solution as a function of the soft X-ray energy from the nitrogen to oxygen K-edge region. The XIL intensities for the nucleotide solutions are significantly enhanced in the soft X-ray region (410-530 eV) which is ascribed to the K-shell excitation/ionization of nitrogen atoms in the nucleobases. Furthermore, the XIL spectra do not show any signature of X-ray absorption near-edge structure (XANES) of the nucleobases. This is because the luminescence intensities collected from the integral area of the micro-jet only reflect the quantum yield of luminescence of the absorbed X-ray into UV-visible light irrespective of the absorption cross sections, i.e. of XANES. Thus the present result is the first evidence of luminescence as a result of X-ray absorption of aqueous nucleotides.


Asunto(s)
ADN/química , ADN/efectos de la radiación , Desoxirribonucleótidos/química , Desoxirribonucleótidos/efectos de la radiación , Diseño de Equipo , Concentración de Iones de Hidrógeno , Luminiscencia , Nitrógeno/química , Oxígeno/química , Sincrotrones , Agua/química , Espectroscopía de Absorción de Rayos X
3.
Phys Rev Lett ; 120(13): 132505, 2018 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-29694189

RESUMEN

We report on the first observation of γ rays emitted from an sd-shell hypernucleus, _{Λ}^{19}F. The energy spacing between the ground state doublet, 1/2^{+} and 3/2^{+} states, of _{Λ}^{19}F is determined to be 315.5±0.4(stat)_{-0.5}^{+0.6}(syst) keV by measuring the γ-ray energy of the M1(3/2^{+}→1/2^{+}) transition. In addition, three γ-ray peaks are observed and assigned as E2(5/2^{+}→1/2^{+}), E1(1/2^{-}→1/2^{+}), and E1(1/2^{-}→3/2^{+}) transitions. The excitation energies of the 5/2^{+} and 1/2^{-} states are determined to be 895.2±0.3(stat)±0.5(syst) and 1265.6±1.2(stat)_{-0.5}^{+0.7}(syst) keV, respectively. It is found that the ground state doublet spacing is well described by theoretical models based on existing s- and p-shell hypernuclear data.

4.
J Radiol Prot ; 34(3): 675-98, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25125455

RESUMEN

Data related to radioactivity released from the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident on 15 March 2011 gathered by residents of Miharu, Fukushima Prefecture, and by Tohoku University are presented. These data sets consist of (1) the earliest radiation monitoring by a Geiger counter in the town, (2) ratios of radioactivity between (132)Te and (137)Cs for a wide area between Fukushima and Tokyo, (3) radiation measurement of soil samples collected from 18 school grounds, and (4) external radiation exposure of 1400 students using OSL badges. By combining and analysing these various data sets, a curve for the cumulative total external exposure as a function of time, with 16 : 00 h on 15 March 2011 being time zero, is obtained. The average cumulative external dosage is estimated to be 10 mSv (σ = 4.2 mSv) over 10 years. In addition, the initiative that the residents of Miharu took in response to the FDNPP accident, which became known as The Misho Project (MP), is documented; in particular, the time at which the municipality instructed the immediate ingestion of iodine tablets by those under the age of 40, 13 : 00 h on 15 March 2011, is assessed.


Asunto(s)
Accidente Nuclear de Fukushima , Plantas de Energía Nuclear , Radiación Ionizante , Radiometría/estadística & datos numéricos , Japón
5.
Phys Rev Lett ; 109(21): 213001, 2012 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-23215591

RESUMEN

The mechanism of DNA modification induced by K-shell photoabsorption of nitrogen and oxygen atoms was investigated by electron paramagnetic resonance and x-ray absorption near edge structure measurements of calf thymus DNA. A g factor of 2.000 for the unpaired electron species, which only arises during irradiation, was measured. The EPR intensities for DNA zwere twofold times larger than those estimated based on the photoabsorption cross section. This suggests that the DNA film itself forms unpaired electron species through the excitation of enhanced electron recapturing, known as the postcollision interaction process.


Asunto(s)
ADN/química , Electrones , Nitrógeno/química , Oxígeno/química , Absorción , Animales , Bovinos , Espectroscopía de Resonancia por Spin del Electrón/métodos , Procesos Fotoquímicos
6.
Methods Find Exp Clin Pharmacol ; 27(9): 645-9, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16357950

RESUMEN

The present study was carried out to determine the involvement of dopamine receptor subtypes D3 and D4, in the discriminative stimulus effects of cocaine in the rats trained to discriminate 10 mg/kg of cocaine from vehicle. The discriminative stimulus effects of cocaine (1-10 mg/kg) were dose-dependent. The dopamine D2 receptor agonist bromocriptine (1.25-20 mg/kg) and the dopamine D3 receptor agonist R(+)-7-OH-DPAT (0.0001-0.3 mg/kg) produced cocaine (10 mg/kg)-like discriminative stimulus effects. Both the dopamine D3 receptor antagonist GR103691 (1 mg/kg) and the dopamine D4 receptor antagonist L745870 (1 mg/kg) partially antagonized the discriminative stimulus effects of cocaine (10 mg/kg) and the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg). L745870 (0.001 mg/kg) inhibited the antagonistic effects of GR103691 (1 mg/kg) on the discriminative stimulus effects of cocaine (10 mg/kg), whereas the drug (0.001 mg/kg) enhanced the antagonistic effects of GR103691 (1 mg/kg) on the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg). GR103691 (1 mg/kg) in combination with L745870 (0.001 mg/kg) did not markedly affect the cocaine (10 mg/kg)-like discriminative stimulus effects of bromocriptine (20 mg/kg). These results suggest that the discriminative stimulus effects of cocaine are different from the cocaine-like discriminative stimulus effects of bromocriptine or R(+)-7-OH-DPAT, in terms of dopamine D3 and D4 receptors.


Asunto(s)
Bromocriptina/farmacología , Cocaína/farmacología , Discriminación en Psicología/efectos de los fármacos , Agonistas de Dopamina/farmacología , Inhibidores de Captación de Dopamina/farmacología , Tetrahidronaftalenos/farmacología , Animales , Compuestos de Bifenilo/farmacología , Masculino , Piperazinas/farmacología , Piridinas/farmacología , Pirroles/farmacología , Ratas , Ratas Endogámicas F344 , Receptores de Dopamina D3/antagonistas & inhibidores , Receptores de Dopamina D4/antagonistas & inhibidores
7.
Phys Rev Lett ; 94(5): 052502, 2005 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-15783631

RESUMEN

In order to produce a neutron-rich Lambda hypernucleus for the first time, we carried out an experiment by utilizing the (pi-,K+) double charge-exchange reaction on a 10B target. We observed the production of a 10LambdaLi hypernucleus. The cross section for the Lambda bound region was found to be 11.3+/-1.9 nb/sr with the 1.2 GeV/c incident momentum, which is compared with the 10LambdaB hypernucleus production cross section, 7.8+/-0.3 microb/sr, in the (pi+,K+) reaction with a 1.05 GeV/c incident momentum beam.

8.
Phys Rev Lett ; 93(23): 232501, 2004 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-15601150

RESUMEN

We have observed two gamma-ray transitions in (16)(Lambda)O from the 6.6 MeV excited 1(-)(2) state to both ground-state spin-doublet members (1(-)(1),0(-)) by the (K-,pi(-)gamma) reaction. We have obtained the ground-state doublet spacing to be 26.4+/-1.6(stat)+/-0.5(syst) keV and the excitation energy of the 1(-)(2) state to be 6561.7+/-1.1(stat)+/-1.7(syst) keV. The ground-state doublet spacing provides a small but nonzero strength of the tensor interaction between a Lambda and a nucleon. This is the first experimental result on the LambdaN tensor interaction.

9.
Ann N Y Acad Sci ; 1025: 424-9, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15542745

RESUMEN

We examined whether dopamine D4 receptor is involved in morphine dependence in mice. Mice pretreated with morphine (10 mg/kg, s.c.) twice a day for 5 days showed withdrawal syndromes such as jumping, rearing, and forepaw tremors after the administration of naloxone (2 mg/kg, i.p.) on the sixth day. Such mice exhibited significant elevation of cAMP levels in the thalamus compared with the control mice. L-745,870 (1 mg/kg, i.p.), a selective dopamine D4 receptor antagonist, pretreated with morphine on the sixth day, significantly attenuated the severity of withdrawal syndromes and the increase in cAMP levels after the administration of naloxone. These results suggest that (1) the elevation of cAMP levels is involved in the expression of morphine-induced withdrawal syndromes, and (2) dopamine D4 receptor antagonists inhibit the expression of morphine-induced withdrawal syndromes accompanied with biochemical changes in mice. Furthermore, dopamine D4 receptor antagonists may be useful drugs for attenuating the expression of morphine dependence.


Asunto(s)
Antagonistas de Dopamina/uso terapéutico , Antagonistas de los Receptores de Dopamina D2 , Dependencia de Morfina/tratamiento farmacológico , Naloxona/farmacología , Piridinas/uso terapéutico , Pirroles/uso terapéutico , Animales , AMP Cíclico/metabolismo , Antagonistas de Dopamina/farmacología , Masculino , Ratones , Dependencia de Morfina/metabolismo , Piridinas/farmacología , Pirroles/farmacología , Receptores de Dopamina D2/metabolismo , Receptores de Dopamina D4 , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Síndrome de Abstinencia a Sustancias/metabolismo
10.
Methods Find Exp Clin Pharmacol ; 25(5): 355-9, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12851657

RESUMEN

The present study was designed to examine the effects of diazepam, nitrazepam, desipramine and haloperidol on tail-swing behavior in mice and to characterize the effects of diazepam. Mice were suspended with rubber bands tied around their upper bodies in order to force their heads upwards. The duration of tail-swing behavior was then measured. Diazepam (0.3 and 1 mg/kg) and nitrazepam (0.3 and 1 mg/kg) significantly depressed tail-swing behavior, while they did not affect ambulation or muscle tone. In contrast, desipramine (10-30 mg/kg) did not affect tail-swing behavior, but at doses of 17.5 and 30 mg/kg produced a marked reduction in ambulation. Haloperidol (0.15 mg/kg) significantly decreased both tail-swing behavior and ambulation. The benzodiazepine receptor antagonist flumazenil (1 and 10 mg/kg), the benzodiazepine receptor inverse agonist beta-carboline-3-carboxylic acid N-methylamide (beta-CCM; 3 mg/kg) and the GABA(A) receptor antagonist bicuculline (3 mg/kg) reversed the effects of diazepam (1 mg/kg) on tail-swing behavior, although administered alone they failed to influence such behavior. These results suggest that anxiety and/or fear are responsible for tail-swing behavior.


Asunto(s)
Ansiedad , Conducta Animal/efectos de los fármacos , Modelos Animales de Enfermedad , Cola (estructura animal)/fisiopatología , Animales , Ansiedad/fisiopatología , Ansiedad/psicología , Desipramina/farmacología , Diazepam/farmacología , Haloperidol/farmacología , Inmovilización , Masculino , Ratones , Tono Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/fisiopatología , Nitrazepam/farmacología , Psicotrópicos/farmacología , Cola (estructura animal)/efectos de los fármacos
11.
J Neural Transm (Vienna) ; 109(9): 1221-5, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12203050

RESUMEN

We investigated the effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice. Mice pre-exposed to inescapable electric footshock were treated with U-50,488H. Stimulation of the kappa-opioid receptor by U-50,488H (10 mg/kg/day, i.p.) attenuated the escape failure induced by pre-exposure to shock. This attenuation by U-50,488H was blocked by MR2266 (10 mg/kg/day, s.c.), an opioid receptor antagonist. These results suggest that the kappa-opioid system plays an important role in the learned helplessness depression in mice.


Asunto(s)
3,4-Dicloro-N-metil-N-(2-(1-pirrolidinil)-ciclohexil)-bencenacetamida, (trans)-Isómero/farmacología , Analgésicos no Narcóticos/farmacología , Encéfalo/metabolismo , Depresión/metabolismo , Trastorno Depresivo/metabolismo , Desamparo Adquirido , Receptores Opioides kappa/metabolismo , Animales , Benzomorfanos/farmacología , Encéfalo/efectos de los fármacos , Encéfalo/fisiopatología , Depresión/tratamiento farmacológico , Depresión/fisiopatología , Trastorno Depresivo/tratamiento farmacológico , Trastorno Depresivo/fisiopatología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Masculino , Ratones , Antagonistas de Narcóticos/farmacología , Péptidos Opioides/metabolismo , Receptores Opioides kappa/agonistas
12.
Neuroreport ; 12(17): 3723-7, 2001 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-11726782

RESUMEN

The effects of intracerebroventricular injection of endomorphin-1 and 2, endogenous mu-opioid receptor agonists, on the scopolamine-induced impairment of spontaneous alternation performance associated with short-term memory were investigated in mice. Endomorphin-1 (0.03 microg) inhibited scopolamine (1 mg/kg)-induced impairment of spontaneous alternation performance without affecting total arm entries, while endomorphin-2 (0.01-10 microg) failed to significantly influence the scopolamine (1 mg/kg)-induced impairment. Endomorphin-1 (0.03 microg) itself had no marked effects on spontaneous alternation performance in intact mice. Although beta-funaltrexamine (5 microg), a mu-opioid receptor antagonist, did not significantly affect the inhibitory effects of endomorphin-1 (0.03 microg) on the scopolamine (1 mg/kg)-induced impairment, naloxonazine (35 mg/kg), a mu1-opioid receptor antagonist, significantly reversed the inhibitory effects of endomorphin-1 (0.03 microg) on the impairment. Naloxonazine (35 mg/kg) unlike beta-funaltrexamine (5 microg) did not significantly influence the scopolamine (1 mg/kg)-induced impairment of spontaneous alternation performance. These results suggest that endomorphin-1 improves the disturbance of short-term memory resulting from cholinergic dysfunction through the mediation of mu1-opioid receptors.


Asunto(s)
Analgésicos Opioides/farmacología , Trastornos de la Memoria/tratamiento farmacológico , Memoria a Corto Plazo/efectos de los fármacos , Antagonistas Muscarínicos/farmacología , Naloxona/análogos & derivados , Naltrexona/análogos & derivados , Oligopéptidos/farmacología , Receptores Opioides mu/agonistas , Escopolamina/antagonistas & inhibidores , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas/fisiología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/fisiopatología , Memoria a Corto Plazo/fisiología , Ratones , Naloxona/farmacología , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Receptores Opioides mu/metabolismo
13.
Br J Pharmacol ; 134(8): 1597-9, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11739234

RESUMEN

Humanin is a very recently discovered 24 amino acid linear polypeptide, which protects against cell death induced by either familial Alzheimer's disease mutant of amyloid precursor protein, presenilin-1 or presenilin-2 in vitro. However, it has remained uncertain whether humanin is a useful drug for the animal model of learning and memory deficit. In this study, we evaluated the effects of [Gly(14)]-humanin, a more potent humanin analogue, on the scopolamine HBr (1 mg kg(-1) s.c.)-induced impairment of spontaneous alternation behaviour in the Y-maze, an index of short-term memory in mice. [Gly(14)]-Humanin (1000 pmol 5 microl(-1) i.c.v.) reversed the impairment without affecting the number of arm entries. These results suggest that (I) [Gly(14)]-humanin is a beneficial drug for the impairment of learning and memory and (II) it modulates the learning and memory function mediated via cholinergic systems in mice.


Asunto(s)
Discapacidades para el Aprendizaje/tratamiento farmacológico , Trastornos de la Memoria/tratamiento farmacológico , Antagonistas Muscarínicos/farmacología , Fármacos Neuroprotectores/farmacología , Péptidos/farmacología , Proteínas/farmacología , Escopolamina/antagonistas & inhibidores , Secuencia de Aminoácidos , Animales , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Conducta Animal/efectos de los fármacos , Defecación/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Péptidos y Proteínas de Señalización Intracelular , Discapacidades para el Aprendizaje/inducido químicamente , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Ratones , Ratones Mutantes , Datos de Secuencia Molecular , Factores de Tiempo
14.
Eur J Pharmacol ; 421(2): 115-9, 2001 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-11399267

RESUMEN

The effects of intracerebroventricular administration of endomorphin-1 and endomorphin-2, endogenous mu-opioid receptor agonists, on passive avoidance learning associated with long-term memory were investigated in mice. Endomorphin-1 (10 and 17.5 microg) and endomorphin-2 (17.5 microg) produced a significant decrease in step-down latency in a passive avoidance learning task. beta-Funaltrexamine (5 microg) almost completely reversed the endomorphin-1 (17.5 microg)- and endomorphin-2 (17.5 microg)-induced shortening of step-down latency, although neither naltrindole (4 ng) nor nor-binaltorphimine (4 microg) produced any significant effects on the effects of endomorphins 1 and 2. These results suggest that endomorphins 1 and 2 impair long-term memory through the mediation of mu-opioid receptors in the brain.


Asunto(s)
Analgésicos Opioides/farmacología , Reacción de Prevención/efectos de los fármacos , Naltrexona/análogos & derivados , Oligopéptidos/farmacología , Animales , Conducta Animal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Masculino , Ratones , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Receptores Opioides mu/agonistas
15.
Jpn J Physiol ; 51(1): 121-5, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11282004

RESUMEN

An expression of mRNA coding the calcium-activated Cl- channel-1 (CLCA1) in rabbit gastric parietal cells was examined to verify the possibility that the CLCA1 mediates housekeeping Cl- channels in the basolateral membrane. In whole-cell voltage-clamp experiments of rabbit parietal cells, A23187 (2 microM), a Ca2+ ionophore, activated the basolateral Cl- channels. The partial cDNA fragment of rabbit CLCA1 could be amplified from the total RNA of tracheal epithelium. A Northern blot analysis showed that rabbit CLCA1 mRNA of 3.4 kb is highly expressed in the tracheal epithelium, but not in the gastric parietal cells. Even in a more sensitive detection of rabbit CLCA1 mRNA by RT-PCR, no signal could be observed in the gastric parietal cells. These results suggest that the CLCA1 protein may not be a subunit of the housekeeping Ca2+ -dependent Cl- channel in the basolateral membrane of rabbit gastric parietal cells.


Asunto(s)
Calcio/farmacología , Canales de Cloruro/fisiología , Células Parietales Gástricas/fisiología , Secuencia de Aminoácidos , Animales , Canales de Cloruro/genética , Masculino , Datos de Secuencia Molecular , ARN Mensajero/análisis , Conejos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estómago/citología
16.
J Neural Transm (Vienna) ; 108(12): 1349-61, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11810400

RESUMEN

Here we report the involvement of nociceptin receptor in tolerance to morphine-induced antinociception and in morphine dependence. There was no different nociceptive perception and antinociceptive effects of morphine between wild-type and the nociceptin receptor knockout mice. Tolerance to morphine (10 mg/kg)-induced antinociception was developed in both wild-type and the nociceptin receptor knockout mice after administration of morphine (10 mg/kg) twice a day for 5 days. When naloxone (5 mg/kg) was administered to mice treated with morphine repeatedly on the 6th day, morphine withdrawal syndrome was observed in both wild-type and the nociceptin receptor knockout mice, which were accompanied by the elevation of cyclic AMP levels. While naloxone benzoylhydrazone (1 mg/kg), a putative antagonist for nociceptin receptor/naloxone benzoylhydrazone-sensitive sites, also induced the morphine withdrawal signs in both wild-type and the nociceptin receptor knockout mice, the jumping signs in the nociceptin receptor knockout mice were less severe than those in wild-type mice. Treatment with naloxone benzoylhydrazone in morphine-dependent wild-type mice caused a significant increase in cyclic AMP levels in the thalamus while it had no effect in the nociceptin receptor knockout mice. The analysis of opioid mu-receptor binding showed no difference between wild-type and the nociceptin receptor knockout mice. These results suggest that the nociceptin receptor/naloxone benzoylhydrazone-sensitive sites contribute to the induction of morphine withdrawal syndrome in part. Furthermore, it is demonstrated that morphine withdrawal syndrome excepting jumping can be induced by naloxone benzoylhydrazone without any changes in the cyclic AMP levels in the thalamus.


Asunto(s)
Analgésicos Opioides/farmacología , Encéfalo/metabolismo , Tolerancia a Medicamentos/fisiología , Dependencia de Morfina/metabolismo , Morfina/farmacología , Naloxona/análogos & derivados , Dolor/metabolismo , Receptores Opioides/deficiencia , Animales , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Encéfalo/efectos de los fármacos , Encéfalo/fisiopatología , AMP Cíclico/metabolismo , Esquema de Medicación , Ratones , Ratones Noqueados , Dependencia de Morfina/fisiopatología , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Dolor/fisiopatología , Dimensión del Dolor/efectos de los fármacos , Ensayo de Unión Radioligante , Receptores Opioides/genética , Síndrome de Abstinencia a Sustancias/metabolismo , Síndrome de Abstinencia a Sustancias/fisiopatología , Receptor de Nociceptina
17.
Eur J Pharmacol ; 395(3): 211-5, 2000 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-10812051

RESUMEN

The effects of intracerebroventricular (i.c.v.) administration of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on the spontaneous alternation performance associated with spatial working memory were investigated in mice. Endomorphin-1 (10 and 17.5 microg) and endomorphin-2 (10 microg) produced a significant decrease in percent alternation without affecting total arm entries. beta-Funaltrexamine (5 microg) almost completely reversed the endomorphin-1 (10 microg)- and endomorphin-2 (10 microg)-induced decrease in percent alternation, although neither naltrindole (4 ng) nor nor-binaltorphimine (4 microg) produced any significant effects on alternation performance. These results suggest that endomorphins impair spatial working memory through the mediation of mu-opioid receptors.


Asunto(s)
Analgésicos Opioides/farmacología , Oligopéptidos/farmacología , Desempeño Psicomotor/efectos de los fármacos , Animales , Inyecciones Intraventriculares , Masculino , Ratones , Naltrexona/análogos & derivados , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Receptores Opioides mu/agonistas
18.
Artículo en Japonés | MEDLINE | ID: mdl-11215155

RESUMEN

This paper describes the influence of stress on learning and memory. The mice receiving inescapable electroshock fail to perform the active conditioned avoidance response of lever-pressing. This is called learned helplessness, which is ameliorated by treatment with antidepressants including one of the selective serotonin reuptake inhibitors (SSRIs). It is of particular interest that posttraumatic stress disease (PTSD) accompanied by memory impairment could be improved by treatment with SSRIs. The different kinds of stress including ischemia, footshock, psychological stress, and forced swimming influence learning and memory as indexed by spontaneous alternation performance as well as passive avoidance learning. In addition, a variety of stresses influence the activity of hormones and neurotransmitters like monoamines, neuropeptides, and excitatory amino acids resulting in changes in learning and memory. Finally, the accumulation of data is necessary to clarify the exact mechanism of stress on learning and memory.


Asunto(s)
Aprendizaje/fisiología , Memoria/fisiología , Estrés Fisiológico/psicología , Animales , Monoaminas Biogénicas/metabolismo , Humanos , Discapacidades para el Aprendizaje/tratamiento farmacológico , Discapacidades para el Aprendizaje/etiología , Trastornos de la Memoria/tratamiento farmacológico , Trastornos de la Memoria/etiología , Neuropéptidos/metabolismo , Neurotransmisores/metabolismo , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , Trastornos por Estrés Postraumático/complicaciones , Trastornos por Estrés Postraumático/metabolismo , Trastornos por Estrés Postraumático/psicología , Estrés Fisiológico/complicaciones , Estrés Fisiológico/metabolismo
19.
Mol Biol Cell ; 10(11): 3633-42, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10564261

RESUMEN

We generated transgenic mice expressing chimeric receptors, which comprise extracellular domains of the human granulocyte-macrophage colony-stimulating factor (hGM-CSF) receptor and transmembrane and cytoplasmic domains of the mouse leukemia inhibitory factor receptor. In suspension cultures of lineage-negative (Lin(-)), 5-fluorouracil-resistant bone marrow cells of the transgenic mice, a combination of hGM-CSF and stem cell factor (SCF) induced exponential expansions of mixed colony-forming unit. The combination of hGM-CSF and SCF was effective on enriched, Lin(-)Sca-1(+)c-kit(+) progenitors and increased either mixed colony-forming unit or cobblestone area-forming cells. In case of stimulation with hGM-CSF and SCF, interleukin-6 (IL-6) and SCF, or IL-11 and SCF, the most efficient expansion was achieved with hGM-CSF and SCF. When Lin(-)Sca-1(+)c-kit(+)CD34(-) further enriched progenitors were clone sorted and individually incubated in the presence of SCF, hGM-CSF stimulated a larger number of cells than did IL-6, IL-6 and soluble IL-6 receptor (IL-6R), or IL-11. These data suggest the presence of IL-6Ralpha-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors. Such primitive progenitors are equipped with signal transduction molecules and can expand when these chimeric receptors are genetically introduced into the cells and stimulated with hGM-CSF in the presence of SCF.


Asunto(s)
Antígenos CD/metabolismo , Inhibidores de Crecimiento , Células Madre Hematopoyéticas/metabolismo , Interleucina-6 , Linfocinas , Glicoproteínas de Membrana/metabolismo , Receptores de Citocinas/metabolismo , Receptores de Interleucina-6/metabolismo , Receptores de Interleucina/metabolismo , Animales , Células Clonales , Ensayo de Unidades Formadoras de Colonias , Receptor gp130 de Citocinas , Citometría de Flujo , Fluorouracilo/farmacología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Humanos , Subunidad alfa del Receptor de Interleucina-11 , Factor Inhibidor de Leucemia , Subunidad alfa del Receptor del Factor Inhibidor de Leucemia , Ratones , Ratones Transgénicos , Receptores de Citocinas/genética , Receptores de Factor Estimulante de Colonias de Granulocitos y Macrófagos/genética , Receptores de Interleucina-11 , Receptores OSM-LIF , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo
20.
Methods Find Exp Clin Pharmacol ; 20(7): 555-60, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9819798

RESUMEN

The present study was designed to clarify whether opioid neuronal systems are involved in the beneficial effects of tachykinins such as the neurokinin NK1 receptor agonist, substance P (SP), the neurokinin NK2 receptor agonist, neurokinin A (NKA), and the neurokinin NK3 receptor agonist, senktide, on the scopolamine-induced impairment of spontaneous alternation performance in mice. Intracerebroventricular injections of SP (0.1 microgram), NKA (0.3 microgram) and senktide (3 ng) inhibited the scopolamine (1 mg/kg)-induced impairment of spontaneous alternation performance without influencing total arm entries, indicating the antiamnesic effects of tachykinins. Furthermore, the inhibitory effects of SP, but not those of NKA or senktide, were almost completely reversed by pretreatment with naloxone (1 mg/kg). However, the effects of SP on the scopolamine-induced impairment of spontaneous alternation performance were not influenced by pretreatment with the mu-opioid receptor antagonist, beta-funaltrexamine (5 micrograms), the delta-opioid receptor antagonist, naltrindole (4 ng), and the kappa-opioid receptor antagonist, nor-binaltorphimine (4 micrograms). These findings suggest that the effects of SP, unlike those of NKA or senktide, on the scopolamine-induced impairment of spontaneous alternation performance associated with spatial working memory are not mediated simply via a single type of opioid receptors, such as mu, delta or kappa.


Asunto(s)
Antagonistas Muscarínicos/farmacología , Desempeño Psicomotor/efectos de los fármacos , Escopolamina/antagonistas & inhibidores , Taquicininas/farmacología , Animales , Masculino , Ratones , Naloxona/farmacología , Naltrexona/análogos & derivados , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Neuroquinina A/farmacología , Fragmentos de Péptidos/farmacología , Escopolamina/farmacología , Sustancia P/análogos & derivados , Sustancia P/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...